NEW YORK, September 22, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following
equities: AEterna Zentaris Inc. (NASDAQ: AEZS),
Great Basin Scientific, Inc. (NASDAQ: GBSN), Gilead
Sciences, Inc. (NASDAQ: GILD), WaferGen Bio-systems,
Inc. (NASDAQ: WGBS), Horizon Pharma plc (NASDAQ: HZNP).
On Monday, September 21, 2015, Nasdaq
ended at 4,828.95, up 0.04%, DOW advanced 0.77% to finish the day
at 16,510.19, and the S&P closed at 1,966.97, up 0.46%.
Register for your complimentary reports at the links given below.
--
AEterna Zentaris Inc.
--
AEterna Zentaris Inc.'s stock edged lower by 32.41% to close
Monday's session at USD 0.08. The
company's shares oscillated between USD 0.07
and USD 0.10. The stock recorded a trading volume of 130.53
million shares, which was above its 50-day daily average volume of
15.41 million shares. Over the last three days AEterna Zentaris
Inc.'s shares have advanced 49.72% and in the past one week the
stock has moved up 48.33%. On a compounded total return basis, the
stock has shown a negative return of 20.77% in the past one month
and of 71.70% in the past three months. The company is having a
market capitalization of USD 9.45
million. The stock is trading at a price to book ratio of
1.31, while the historical PB ratio is near to 2.71. Additionally,
the stock is trading at a price to sales ratio of 37.33. Sign up
and read the free notes on AEZS at:
http://www.aciassociation.com/AEZS.pdf
--
Great Basin Scientific Inc.
--
The stock of Great Basin Scientific Inc. gained 37.45% to close
Monday's session at USD 0.07. The
shares of the company moved in the range of USD 0.05 and USD
0.08. A trading volume of 121.09 million shares was
recorded, which was greater than its 150-day daily average volume
of 3.48 million shares and above its 52-week average volume of 2.20
million shares. Over the last five days Great Basin Scientific
Inc.'s shares have declined by 18.25% and in the past one month the
stock has lost 96.69%. The stock has shown a negative return of
97.98% in the past three months and of 96.62% in the last half
year, on a compounded total return basis. Register for free on ACI
Association and access the latest research on GBSN at:
http://www.aciassociation.com/GBSN.pdf
--
Gilead Sciences Inc.
--
Gilead Sciences Inc.'s stock decreased by 2.49% to close
Monday's session at USD 105.74. A
total of 15.14 million shares exchanged hands, which surpassed its
50-day daily average volume of 10.80 million shares. Over the last
three days Gilead Sciences Inc.'s shares have declined by 4.76% and
in the past one week the stock has moved down 3.30%. The company
has returned 0.61% in the past one month and 4.16% in the last half
year, on a compounded total return basis. Gilead Sciences Inc. has
a current dividend yield of 1.59%. The stock is trading at a price
to earnings ratio of 11.10, compared to a historical PE ratio of
12.83. Further, the stock is at a price to book ratio of 9.56,
while the historical PB ratio is near to 9.16. The complete
research on GILD is available for free at:
http://www.aciassociation.com/GILD.pdf
--
WaferGen Bio-systems Inc.
--
WaferGen Bio-systems Inc.'s stock added 90.06% to close Monday's
session at USD 3.25. The company's
shares oscillated between USD 1.71 and USD
3.47. The stock recorded a trading volume of 14.82 million
shares, which was above its 50-day daily average volume of 0.49
million shares and above its 52-week average volume of 0.19 million
shares. Over the last five days WaferGen Bio-systems Inc.'s shares
have advanced 112.42% and in the past one month the stock has
gained a momentum of 146.21%. In addition, over the last three
months the stock has lost 12.87% and year to date the shares have
picked up 8.33%. The company has returned 164.21% in the past one
month and a negative return of 17.51% in the past three months, on
a compounded total return basis. Free in-depth research on WGBS is
available at: http://www.aciassociation.com/WGBS.pdf
--
Horizon Pharma PLC
--
Horizon Pharma PLC's stock declined 9.18% to close Monday's
session at USD 28.99. The share price
vacillated between USD 28.73 and USD
32.34. The stock recorded a trading volume of 8.24 million
shares, which was above its 50-day daily average volume of 2.85
million shares. Over the last three days Horizon Pharma PLC's
shares have advanced 0.28% but in the past one week the stock has
moved down 0.10%. Moreover, in the last six months the stock has
gained 30.94% and year to date the shares have picked up 124.90%.
On a compounded total return basis, the company has returned 27.32%
in the last half a year and 143.00% in the past one year. The stock
is trading at a price to book ratio of 3.66, while the historical
PB ratio is near to 2.98. Additionally, the stock is trading at a
price to sales ratio of 7.92. The complimentary notes on HZNP can
be downloaded in PDF format at:
http://www.aciassociation.com/HZNP.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com